News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR awarded prestigious prize for radiotherapy research
The Institute of Cancer Research, London, has been awarded a Queen Elizabeth Prize for Higher and Further Education - the highest national honour in UK further and higher education for its pioneering radiotherapy research.
.png?sfvrsn=364266fe_1 "Image of hand holding syringe (1280 x 400 px)")
‘Smart jab’ shows promise in treating advanced head and neck cancer
A new type of cancer treatment which is given via an injection under the skin has shown early signs of success in patients with advanced head and neck cancer.
---945x532.jpg?sfvrsn=73000500_2 "radiotherapy IMRT (photo: Jan Chlebik/the ICR) - 945x532")
Cutting-edge proton beam therapy is no better than advanced radiotherapy for treating head and neck cancer
Cutting edge proton beam therapy is no better than intensity-modulated radiotherapy for treating people with head and neck cancer, according to new findings from a nationwide clinical trial.
-being-attacked-by-two-cytotoxic-t-cells-(red)-547x410.tmb-hbmobile.png?Culture=en&sfvrsn=8f59440b_2 "Immunotherapy - Oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red) 547x410")
ASCO 2025: Immunotherapy gives head and neck cancer patients extra years disease-free
An immunotherapy helps patients live years longer without their cancer getting worse or coming back, a major phase III trial has found.
ICR and life sciences company QBiotics launch new collaboration to study potential cancer drug derived from rainforest tree species
Scientists at The Institute of Cancer Research, London, are collaborating with life sciences company QBiotics to unravel the molecular and cellular mechanisms of a potential new cancer drug.
Innovative imaging study confirms feasibility of using smaller target areas in radiotherapy for early-stage glottic cancer
Scientists have successfully used real-time MRI to demonstrate that swallowing causes minimal motion of the larynx, known as the voice box, in people undergoing a radiotherapy session for cancer in this part of the body.
New method could lower radiotherapy doses for some cancer patients
A special type of MRI scan where patients inhale 100% oxygen could result in lower radiotherapy doses for some cancer patients.
Trial results support ‘new gold standard’ for head and neck cancer radiotherapy
Phase 3 trial results on a precision radiotherapy technique support a ‘new gold standard’ for treating head and neck cancer patients. The research suggests the new approach can reduce the risk of swallowing problems after radiotherapy, without impacting the success of treatment.
Immunotherapy shows promise as a kinder first-line treatment for advanced head and neck cancers
Immunotherapy can extend the response of some head and neck tumours to treatment, maintaining the anti-tumour effects and preventing them from growing or spreading for longer, a study reports.
Scientific achievements of 2022
We have picked 10 exciting scientific discoveries from the past academic year that brilliantly showcase the quality, breadth and strategic impact of our research.
ASCO 2022: 'Practice-changing' radiotherapy technique can reduce swallowing problems for cancer patients
A new precision radiotherapy technique described as ‘practice changing’ has been shown to reduce long-term side effects, including swallowing problems, for patients with head and neck cancer following treatment.
First UK clinical trial in proton beam therapy
The first proton beam therapy clinical trial in the UK, co-led by The Institute of Cancer Research, London, is now taking place at The Christie NHS Foundation Trust in Manchester.
